NYSE (USA) TSX (CANADA)

Directory of Stock Market Company

This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.

Search into NYSE and TSX
by quote, company name or key word

facebooktwitterlinkedin
Mail

ARAY - Accuray Inc

Accuray Incorporated, incorporated in 1990, has developed a robotic radiosurgery system, CyberKnife Robotic Radiosurgery System, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery. Its CyberKnife system represents the radiosurgery systems, combining continuous image-guidance technology with a compact linear accelerator (linac). Its image-guidance technology enables the system to acquire ima","NYSE, Nasdaq, S&P, trading, US market, Asian market, Dow Jones, FTSE, DJIA, DAX, stocks, bonds, shares","Connect to the most current information on stocks and bonds on Reuters.com. What you need to know now about NYSE, Dow Jones, S&P, and Nasdaq at Reuters.com"

# ARAYhart

Accuray Inc News


QUAN Works to Take Robotics Out of the Lab and Into the Marketplace
MarketWatch (press release) - 18 hours ago
HOUSTON, May 21, 2012 (BUSINESS WIRE) -- Promising new robotics innovations may be poised to improve our lives forever, but many breakthroughs are still years away from commercial availability.

Accuray Appoints Richard Pettingill, LFACHE to Board of Directors
MarketWatch (press release) - May 17, 2012
SUNNYVALE, Calif., May 17, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated (NASDAQ:ARAY) , the premier radiation oncology company, announced today the appointment of Richard Pettingill, LFACHE as a member of the company's Board of Directors ...

ACCURAY INCORPORATED : Full Breadth and Depth of Accuray's Advanced ...
4-traders - May 16, 2012
SUNNYVALE, Calif., May 16, 2012 - Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that for the first time in Europe, at ESTRO 31, the Annual Congress of the European Society for Therapeutic Radiology and ...

Varian Medical Remains Neutral
Zacks.com - May 16, 2012
We reiterate our Neutral rating on Varian Medical Systems (VAR - Analyst Report). Its second-quarter fiscal 2012 earnings per share of 96 cents matched the Zacks Consensus Estimate.

A Hidden Reason Accuray's Future Looks Bright
DailyFinance - May 16, 2012
By Seth Jayson, The Motley Fool Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels.

Has Accuray Become the Perfect Stock?
DailyFinance - May 15, 2012
By Dan Caplinger, The Motley Fool Every investor would love to stumble upon the perfect stock. But will you ever really find a stock that provides everything you could possibly want?

Accuray Incorporated to Speak at B. Riley & Company 13th Annual Investor ...
MarketWatch (press release) - May 15, 2012
SUNNYVALE, Calif., May 15, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated (NASDAQ:ARAY) , the premier radiation oncology company, announced today that its management is scheduled to present at the B. Riley & Company 13th Annual Investor ...

Accuray Incorporated to Speak at B. Riley & Company 13th Annual Investor ...
PR Newswire (press release) - May 15, 2012
SUNNYVALE, Calif., May 15, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the B. Riley & Company 13th Annual Investor Conference in Los ...

QUAN: Home Care Robots Could Transform Personal Assistance Market
MarketWatch (press release) - May 15, 2012
HOUSTON, May 15, 2012 (BUSINESS WIRE) -- As the world's population ages, Quantum International Corp. (OTN:QUAN) is exploring new opportunities to deliver advanced personal assistance robots capable of helping the elderly and chronically ill lead more ...

Accuray Increases Sales but Misses Revenue Estimate
DailyFinance - May 14, 2012
By Seth Jayson, The Motley Fool Accuray (NAS: ARAY) reported earnings on May 8. Here are the numbers you need to know. For the quarter ended March 31 (Q3), Accuray missed slightly on revenues and exceeded expectations on earnings per share.

NYSE Media Coverage Selection of the best articles found in your favorit medias

Next Company >>